The Integrative Cancer Genomics Shared Resource operates a continually updated facility to provide state-of- the-art instrumentation and protocol support to Duke Cancer Institute (DCI) researchers. The Shared Resource was created by the recent merger of two existing units at Duke: the Microarray Core Facility and the Genome Sequencing and Analysis Core Facility. Each of these predecessors has a track record more than a decade long of providing constantly updated, state-of-the-art genomic services to DCI members. Until recently, however, only the Microarray Core Facility had a partnership with the DCI and was supported by it. The new Integrative Cancer Genomics Shared Resource brings all of the genomic technologies on campus under a single organization and enables comprehensive consultation, seamless management of complex projects that span multiple services, enhanced operational flexibility, and economies of scale for support services such as IT and accounting. DCI members receive scheduling priority for Shared Resource services including SNP discovery, mapping chromatin modifications, measuring mRNA levels at several scales (single genes, cancer panels, entire transcriptome), sequencing exomes, identifying DNA methylation, and mapping transcription factor binding sites. The Shared Resource assists investigators with data quality control, versioning, statistical analysis, and dissemination for all of these services. The staff includes a Director who runs his own research lab, three full-time PhD level staff members, and seven highly experienced technicians. The Resource operates primarily on a cost-recovery basis, with institutional support for a portion of the operating costs and instrument purchases. Support from the DCI and Cancer Center Support Grant allows the Resource to provide consultations and assistance with grant and manuscript preparation to DCI members free of charge. User fees for other activities follow School of Medicine guidelines. DCI members account for approximately 39% of microarray service users and 14% of DNA sequencing service users of the Integrative Cancer Genomics Shared Resource. Use of the Resource contributed to 444 DCI publications during the funding period. The immediate goal of the Resource is to complete the merger of the predecessor cores. Its long-range objectives are (1) to continue offering start-to-finish, customized support to cancer researchers seeking genomic analyses, and (2) to continually update its instrumentation and range of services to keep pace with technological advances and to meet the needs of DCI members.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-45
Application #
9620038
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
45
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Galaz-Montoya, Monica; Wright, Sara J; Rodriguez, Gustavo J et al. (2017) ?2-Adrenergic receptor activation mobilizes intracellular calcium via a non-canonical cAMP-independent signaling pathway. J Biol Chem 292:9967-9974
Lanier, Megan L; Park, Hyeri; Mukherjee, Paramita et al. (2017) Formal Synthesis of (+)-Laurencin by Gold(I)-Catalyzed Intramolecular Dehydrative Alkoxylation. Chemistry 23:7180-7184
Shi, Qiong; Liu, Hongliang; Han, Peng et al. (2017) Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. J Invest Dermatol 137:1749-1756
Woyach, Jennifer A; Ruppert, Amy S; Guinn, Daphne et al. (2017) BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia. J Clin Oncol 35:1437-1443
Wang, Yanru; Freedman, Jennifer A; Liu, Hongliang et al. (2017) Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer 141:731-743
Fayanju, Oluwadamilola M; Hall, Carolyn S; Bauldry, Jessica Bowman et al. (2017) Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer. Am J Surg 214:666-671
Leu, David; Spasojevic, Ivan; Nguyen, Huy et al. (2017) CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP5. Redox Biol 12:864-871
Sauer, Scott J; Tarpley, Michael; Shah, Imran et al. (2017) Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells. Carcinogenesis 38:252-260
Pan, Yongchu; Liu, Hongliang; Wang, Yanru et al. (2017) Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep 7:44634
Yin, Jieyun; Liu, Hongliang; Liu, Zhensheng et al. (2017) Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol Carcinog 56:1663-1672

Showing the most recent 10 out of 480 publications